This science-backed formula gives your body the tools it needs to naturally support GLP-1 production while working in harmony with a healthy lifestyle
Research Background & Published Literature BPC-157 is among the better documented gastric peptides in preclinical literature
Yeast NDI1 improves oxidative phosphorylation capacity and increases protection against oxidative stress and cell death in cells carrying a Lebers hereditary optic neuropathy mutation
"This bridge program will now allow Medicare beneficiaries access to GLP-1 medications for weight loss through a monthly subscription model, which raises important questions about who pays, how much it will cost, and whether the program can be sustained long term," Kevin Thompson, the CEO of 9i Capital Group and the host of the 9innings podcast, told Newsweek
doi: 10.1161/01.cir.95.1.76
They lost about 4.8% more weight on average than those who took a fake pill (placebo)